Osteoarthritis therapy study advances with $17 million from ARPA-H
October 14, 2026
October 14, 2026
ST. LOUIS, Missouri, Oct. 14 -- The Washington University School of Medicine posted the following news release:
* * *
Osteoarthritis therapy study advances with $17 million from ARPA-H
*
Funding will support collaboration to move single-injection treatment to reverse joint damage into clinical trials
In Brief
* WashU Medicine has received $17 million from ARPA-H to develop an injectable osteoarthritis treatment.
. . .
* * *
Osteoarthritis therapy study advances with $17 million from ARPA-H
*
Funding will support collaboration to move single-injection treatment to reverse joint damage into clinical trials
In Brief
* WashU Medicine has received $17 million from ARPA-H to develop an injectable osteoarthritis treatment.
. . .